SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-319571
Filing Date
2018-11-06
Accepted
2018-11-06 16:11:36
Documents
55
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d625004d10q.htm 10-Q 766331
2 EX-10.1 d625004dex101.htm EX-10.1 1343657
3 EX-31.1 d625004dex311.htm EX-31.1 10738
4 EX-31.2 d625004dex312.htm EX-31.2 10721
5 EX-32.1 d625004dex321.htm EX-32.1 5870
12 GRAPHIC g625004dsp220.jpg GRAPHIC 4677
  Complete submission text file 0001193125-18-319571.txt   4678323

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT gbt-20180930.xml EX-101.INS 571365
7 XBRL TAXONOMY EXTENSION SCHEMA gbt-20180930.xsd EX-101.SCH 33057
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gbt-20180930_cal.xml EX-101.CAL 52461
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gbt-20180930_def.xml EX-101.DEF 130831
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gbt-20180930_lab.xml EX-101.LAB 300502
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gbt-20180930_pre.xml EX-101.PRE 230944
Mailing Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37539 | Film No.: 181163085
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1